Can blood gene expression predict which patients with multiple sclerosis will respond to interferon?

被引:2
|
作者
Kaminski, N [1 ]
Achiron, A
机构
[1] Univ Pittsburgh, Sch Med, Dorothy P & Richard P Simmons Ctr Interstitial Lu, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA 15260 USA
[2] Univ Pittsburgh, Sch Med, Lung Translat Genom Ctr, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA USA
[3] Chaim Sheba Med Ctr, Multiple Sclerosis Ctr, IL-52621 Tel Hashomer, Israel
[4] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel
关键词
D O I
10.1371/journal.pmed.0020033
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:105 / 107
页数:3
相关论文
共 50 条
  • [31] Magnetization transfer can predict clinical evolution in patients with multiple sclerosis
    A. Carlos Santos
    Sridar Narayanan
    Nicola de Stefano
    M. Carmela Tartaglia
    Simon J. Francis
    Rozie Arnaoutelis
    Zografos Caramanos
    Jack P. Antel
    G. Bruce Pike
    Douglas L. Arnold
    Journal of Neurology, 2002, 249 : 662 - 668
  • [32] What can be done for patients with chronic hepatitis C, which have failed to respond to interferon monotherapy?
    Iacob, R
    Iacob, S
    Diculescu, M
    JOURNAL OF HEPATOLOGY, 2002, 36 : 112 - 112
  • [33] Assessment of cryptochrome gene expression in multiple sclerosis patients
    Bayat, S.
    Sajedi, S. A.
    Nabavi, S.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 956 - 956
  • [34] Glypican 5 is an interferon-β response gene in multiple sclerosis patients
    Cenit, M. C.
    Blanco, F.
    Bartolome, M.
    Martinez, A.
    Alvarez-Lafuente, R.
    de Las Heras, V.
    Arroyo, R.
    MULTIPLE SCLEROSIS, 2009, 15 (09): : S184 - S184
  • [35] Enhancement of Chemokine Expression by Interferon Beta Therapy in Patients With Multiple Sclerosis
    Cepok, Sabine
    Schreiber, Herbert
    Hoffmann, Steve
    Zhou, Dun
    Neuhaus, Oliver
    von Geldern, Gloria
    Hochgesand, Sonja
    Nessler, Stefan
    Rothhammer, Veith
    Lang, Michael
    Hartung, Hans-Peter
    Hemmer, Bernhard
    ARCHIVES OF NEUROLOGY, 2009, 66 (10) : 1216 - 1223
  • [36] Trail expression rates of multiple sclerosis patients relation with interferon therapy
    Kurne, A.
    Canpinar, H.
    Aydin, O. F.
    Sayat, G.
    Guec, D.
    Karabudak, R.
    MULTIPLE SCLEROSIS, 2007, 13 : S162 - S162
  • [37] A comparison of gene expression profiles from systemic lupus erythematosus patients with multiple sclerosis patients on interferon therapy.
    Kornu, R
    Dao, KH
    White, AM
    Muir, M
    Li, Q
    Branch, V
    Racke, MK
    Karp, DR
    Wakeland, EK
    Davis, LS
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S612 - S613
  • [38] Gene expression profiles of proteins involved in Cladribine metabolism in peripheral blood of multiple sclerosis patients
    Mechelli, R.
    Manfre, G.
    Buttari, F.
    Gambardella, S.
    Ferraldeschi, M.
    Morena, E.
    Visconti, A.
    Centonze, D.
    Ristori, G.
    Salvetti, M.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 799 - 800
  • [39] Interferon gamma producing blood lymphocytes are decreased by interferon beta therapy in patients with multiple sclerosis
    Petereit, HF
    Bamborschke, S
    Esse, AD
    Heiss, WD
    MULTIPLE SCLEROSIS, 1997, 3 (03): : 180 - 183
  • [40] Gene expression profiles of peripheral blood mononuclear cells in newly diagnosed multiple sclerosis patients
    Rinaldi, L
    D'Arrigo, A
    Fabris, M
    Luise, D
    Terrazzino, S
    Calabrese, M
    Motta, M
    Ranzato, F
    Digito, M
    Gallo, P
    Leon, A
    NEUROLOGY, 2005, 64 (06) : A87 - A87